MSB 7.69% $1.19 mesoblast limited

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-114

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    If the NIH (or whoever the 'partner' is that SI mentions in the Edison Group video) are going to fund this additional Remestemcel-L COVID-19 ARDS phase 3 trial I sure wish they would get a move on - more than 6,000 people have died from COVID-19 in the last 48 hours in the USA so the situation is getting worse, certainly not better


    Wednesday 26th Jan
    upload_2022-1-27_14-28-24.png

    Tuesday 25th Jan
    upload_2022-1-27_14-27-44.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.